Laurel Wealth Advisors (California)’s Moderna MRNA Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio MRNA Stock Details MRNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$309K	Sell
2022 Q3	$222K	Sell
2022 Q2	$270K	Sell
2022 Q1	$423K	Sell
2021 Q4	$627K	Buy
2021 Q3	$746K	Buy
2021 Q2	$453K	Buy